Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
Tags:
clinical trials
,
Sarepta Therapeutics
,
DMD
,
Elevidys
,
Bridge Bio
,
ATTR-CM
,
acoramidis
,
Sanofi
,
Merck KGaA
,
MS
,
tolebrutinib
,
Pfizer
,
obesity
,
danuglipron
,
Novo Nordisk
,
Ozempic
,
Verve Therapeutics
,
heterozygous familial hypercholesterolemia
,
Roche
,
lung cancer
,
tiragolumab
,
Vertex Pharmaceutical
,
VS-548
,
pain
,
JNJ
,
Bristol Myers Squibb
Abiomed’s Impella Now Linked to 4 Deaths in Recent Recall
Medical Devices and Diagnostics Industry
Sun, 08/6/23 - 09:31 pm
Tags:
Medtech
,
Abiomed
,
JNJ
,
Impella
,
TAVR
,
patient deaths
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
Tags:
injectables
,
cancer
,
JNJ
,
Bristol Myers Squibb
,
Halozyme
,
drug pricing
Big Pharma CEOs get candid about pricing and M&A
Pharma Voice
Mon, 07/31/23 - 10:03 am
Tags:
Big Pharma
,
Pharma CEOs
,
drug pricing
,
M&A
,
JNJ
,
Merck
,
GSK
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Fierce Pharma
Wed, 07/26/23 - 06:37 pm
Tags:
JNJ
,
Alkermes
,
oncology
,
earnings
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
Tags:
JNJ
,
GSK
,
ViiV
,
Gilead Sciences
,
HIV
,
Cabenuva
,
Biktarvy
J&J outlines exchange offer for Kenvue shares
Medical Marketing and Media
Mon, 07/24/23 - 09:39 pm
Tags:
JNJ
,
Kenvue
,
shareholders
Pfizer, Gilead, GSK to Capture Growing Infectious Diseases Market as J&J Pulls Back
BioSpace
Mon, 07/24/23 - 10:26 am
Tags:
infectious diseases
,
Pfizer
,
Gilead Sciences
,
GSK
,
JNJ
J&J’s 2Q23 Results Show It’s a Force to Be Reckoned with in Medtech
Medical Devices and Diagnostics Industry
Sun, 07/23/23 - 12:40 pm
Tags:
JNJ
,
Medtech
,
earnings
J&J flags potential interference between heart pump and TAVR stents in recall
Medtech Dive
Fri, 07/21/23 - 11:56 am
Tags:
JNJ
,
Abiomed
,
TAVR
,
Impella
,
device recalls
,
Medtech
J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers
BioSpace
Thu, 07/20/23 - 09:51 pm
Tags:
JNJ
,
earnings
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
Tags:
JNJ
,
Janssen
,
infectious disease
,
vaccines
,
hepatitis
,
HIV
Abiomed’s Impella System Hit with Another Recall
Medical Devices and Diagnostics Industry
Wed, 07/19/23 - 05:47 pm
Tags:
JNJ
,
Abiomed
,
Impella
,
TAVR
,
device recalls
,
Medtech
J&J ordered to pay mesothelioma patient $18.8M in talc case, pledges to appeal
Fierce Pharma
Wed, 07/19/23 - 11:46 am
Tags:
JNJ
,
legal
,
mesothelioma
House Judiciary Committee Probes Big Pharma’s Potential Role in COVID-19 Censorship
BioSpace
Wed, 07/19/23 - 10:23 am
Tags:
Pfizer
,
JNJ
,
Merck
,
Big Pharma
,
COVID-19
,
US Congress
Johnson & Johnson becomes 4th drugmaker to file suit against IRA's drug price negotiations
Fierce Pharma
Tue, 07/18/23 - 10:07 pm
Tags:
JNJ
,
drug pricing
,
Inflation Reduction Act
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
Tags:
JNJ
,
Rybrevant
,
non-small cell lung cancer
,
Takeda
,
Tagrisso
See which pharma brands are the strongest and fastest-growing in 2023
Medical Marketing and Media
Wed, 07/12/23 - 11:12 pm
Tags:
JNJ
,
Pfizer
,
CSL
,
branding
J&J's Ethicon Faces Mega Electrode Recall
Medical Devices and Diagnostics Industry
Wed, 07/12/23 - 09:26 am
Tags:
Medtech
,
JNJ
,
Ethicon
,
electrodes
,
device recalls
,
electrosurger
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Medical Marketing and Media
Tue, 07/11/23 - 11:27 pm
Tags:
JNJ
,
Janssen
,
Nanobiotix
,
NBTXR3
,
soft tissue sarcoma
,
Hensify
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.